封面
市場調查報告書
商品編碼
2020005

全球生物安全櫃市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Biosafety Cabinet Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計生物安全櫃市場將從 2025 年的 2.7491 億美元成長到 2034 年的 4.7081 億美元,2026 年至 2034 年的複合年成長率為 6.16%。

受生物技術、製藥和醫療保健領域研究活動日益活躍的推動,全球生物安全櫃市場正經歷強勁成長。生物安全櫃是重要的實驗室設備,用於保護研究人員、樣本和環境免受有害生物因素的侵害。對感染疾病研究、疫苗開發和微生物學研究的日益重視,顯著提升了對這些安全系統的需求。

實驗室設備的科技進步和日益嚴格的實驗室安全監管標準正進一步推動市場成長。現代生物安全櫃配備了先進的過濾系統、改進的氣流控制和增強的用戶安全功能。此外,科研實驗室、診斷中心和製藥生產設施的擴建也推動了全球生物安全櫃的普及應用。

隨著生命科學研究投入的持續成長,生物安全櫃市場預計將穩定成長。人們對實驗室安全和生物安保意識的不斷提高將進一步推動對先進生物安全防護解決方案的需求。此外,實驗室技術的不斷創新也將促進更有效率、更可靠的生物安全設備的研發。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球生物安全櫃市場:依產品類型分類

  • 市場分析、洞察與預測
  • 一級
  • 二類
  • 三級

第5章 全球生物安全櫃市場:依應用分類

  • 市場分析、洞察與預測
  • 危險化學品的處理
  • 非危險化學品的處理
  • 其他產品處理

第6章 全球生物安全櫃市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 診斷和檢測實驗室
  • 學術研究機構
  • 其他(CRO、CMO、專科診所等)

第7章 全球生物安全櫃市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Labconco Corporation
    • Esco Micro Pte. Ltd
    • The Baker Company
    • NuAire Inc
    • Germfree Laboratories LLC
    • Euroclone SpA
    • Kewaunee International Group
    • Telstar(Azbil Group)
    • Biobase Biodustry(Shandong)Co. Ltd
    • Air Science USA LLC
簡介目錄
Product Code: VMR112112120

The Biosafety Cabinet Market size is expected to reach USD 470.81 Million in 2034 from USD 274.91 Million (2025) growing at a CAGR of 6.16% during 2026-2034.

The global biosafety cabinet market is witnessing strong growth due to increasing research activities in biotechnology, pharmaceuticals, and healthcare. Biosafety cabinets are essential laboratory equipment used to protect researchers, samples, and the environment from harmful biological agents. The rising focus on infectious disease research, vaccine development, and microbiological studies is significantly boosting demand for these safety systems.

Technological advancements in laboratory equipment and strict regulatory standards for laboratory safety are further supporting market growth. Modern biosafety cabinets offer advanced filtration systems, improved airflow control, and enhanced user safety features. Additionally, the expansion of research laboratories, diagnostic centers, and pharmaceutical manufacturing facilities is increasing the adoption of these cabinets worldwide.

In the future, the biosafety cabinet market is expected to grow steadily as investments in life sciences research continue to rise. Increasing awareness about laboratory safety and biosecurity will further drive demand for advanced containment solutions. Furthermore, ongoing innovations in laboratory technologies will support the development of more efficient and reliable biosafety equipment.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Class I
  • Class II
  • Class III

By Application

  • Hazardous Drug Handling
  • Non-hazardous Drug Handling
  • Other Product Handling

By End User

  • Pharmaceutical & Biotechnology Companies
  • Diagnostic & Testing Laboratories
  • Academic & Research Institutes
  • Others (CROs, CMOs, Specialty Clinics, etc.)

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, Labconco Corporation, Esco Micro Pte Ltd, The Baker Company, NuAire Inc, Germfree Laboratories LLC, Euroclone SpA, Kewaunee International Group, Telstar Azbil Group, Biobase Biodustry Shandong Co Ltd, Air Science USA LLC
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOSAFETY CABINET MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Class I Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Class II Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Class III Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOSAFETY CABINET MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Hazardous Drug Handling Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Non-hazardous Drug Handling Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Other Product Handling Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOSAFETY CABINET MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostic & Testing Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others (CROs, CMOs, Specialty Clinics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOSAFETY CABINET MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOSAFETY CABINET INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Thermo Fisher Scientific Inc
    • 9.2.2 Labconco Corporation
    • 9.2.3 Esco Micro Pte. Ltd
    • 9.2.4 The Baker Company
    • 9.2.5 NuAire Inc
    • 9.2.6 Germfree Laboratories LLC
    • 9.2.7 Euroclone SpA
    • 9.2.8 Kewaunee International Group
    • 9.2.9 Telstar (Azbil Group)
    • 9.2.10 Biobase Biodustry (Shandong) Co. Ltd
    • 9.2.11 Air Science USA LLC